Actively Recruiting

Phase 1
Age: 18Years +
FEMALE
NCT02637934

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-04-07

35

Participants Needed

1

Research Sites

559 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Up to 40 evaluable women with known or suspected epithelial ovarian, fallopian tube, or primary peritoneal cancer will participate in two different imaging cohorts. The Biodistribution cohort will include up to 4 patients and the Dynamic cohort will include up to 36 patients. Human dosimetry will be calculated from the Biodistribution cohort. The Dynamic cohort date will evaluate preliminary information on uptake of \[18F\]FTT in gynecological cancer and compare with PARP-1 activity in tissue.

CONDITIONS

Official Title

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 18 years of age or older
  • History of known or suspected epithelial ovarian, fallopian tube, or primary peritoneal cancer, including primary or recurrent cancer
  • At least one lesion 1.0 cm or larger visible on standard imaging such as CT, MRI, ultrasound, or FDG PET/CT
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding females at the time of screening
  • Inability to tolerate imaging procedures as determined by a physician
  • Any medical condition or illness that could compromise safety or study participation as assessed by a physician

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

F

Fiona Simpkins, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT | DecenTrialz